American Urological Association 1000 Corporate Boulevard, Linthicum MD 21090 USA Phone Toll Free (U.S. only): 1-866-RING AUA (1-866-746-4282) Phone: 410-689-3700 Fax: 410-689-3912 Email: [email protected] or [email protected] AUA ID: ,

Transcript of Continuing Medical Education Year: 2017 Program Code

Program

UPDATESERIES16-27 Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer UPDATESERIES16-40 Evaluation and Management of Retroperitoneal Fibrosis

Learning Format

Accredited Provider

Enduring Material Enduring Material

AUA AUA

Location Linthicum, MD Linthicum, MD

Date

AMA PRA Category 1 Credits™

1/5/17

0.75

1/6/17

1.00

Sub Total for 2017 AMA PRA Category 1 Credits™:

1.75

Year: 2016 Program Code

Program

UPDATESERIES15-40 Dealing with the Difficult Patient Encounter updateseries12-10 CPS15-2

Recurrent Urinary Tract Infections in Healthy Premenopausal and Postmenopausal Women Clinical Problem Solving (CPS) Protocol: Medical Management of Kidney Stones

UPDATESERIES15-23 Renal Function after Renal Cancer Surgery 15NOLAW093PG UPDATESERIES16-6

Sequencing Novel Agents and Understanding Novel Concepts 2015 Webcast Early Genital Surgery in Children with Disorders of Sex Development: Concerns, Consents, Conundrum

JU14-10

The Journal of Urology Vol. 192 (10), October 2014

JU16-3

The Journal of Urology Vol. 195(3), March 2016

UPDATESERIES15-1

Erectile Dysfunction in the Younger Man

UPDATESERIES16-13 The Emerging Role of Image Targeting in Contemporary Prostate Biopsy A Decade of Pharmacotherapy for OAB: What Have We Learned 15NOLAWFROAB Webcast UPDATESERIES15-16 Botulinum Toxin Use in the Lower Urinary Tract in Adults and Children Point-Counterpoint: Radical Prostatectomy Should be Encouraged to 16SANPLIISA-3 Men at Any Age 16SANPLISA

Plenary Total - Saturday

16SANPLISA-1

Point-Counterpoint: Mitomycin C for Refractory Bladder Neck Contracture

Learning Format

Accredited Provider

Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Live Activity Live Activity Live Activity

AUA AUA

Location Linthicum, MD Linthicum, Md

Date

AMA PRA Category 1 Credits™

1/3/16

1.00

1/16/16

1.00

AUA

Internet

1/28/16

2.00

AUA

Linthicum, MD

3/3/16

1.00

AUA

Internet

3/11/16

3.00

AUA

Linthicum, MD Linthicum, MD

3/21/16

1.00

3/27/16

2.00

AUA

Internet

4/9/16

2.00

AUA

Linthicum, MD Linthicum, MD

4/12/16

1.00

4/18/16

1.00

AUA

Internet

4/19/16

2.00

AUA

Linthicum, MD San Diego, CA San Diego, CA San Diego, CA

5/1/16

1.00

AUA

AUA

AUA AUA AUA

5/7/16 5/7/16 5/7/16

4.25

16SANPLISA-10

Journal of Urology 2015: Top Papers: Prostate and Testis Cancer

16SANPLISA-11

Journal of Urology 2015: Top Papers: Bladder and Renal Cancer

16SANPLISA-12

Journal of Urology 2015: Top Papers: Investigative Urology

16SANPLISA-13

Panel Discussion: Robots on the Horizon

16SANPLISA-14

Critical Discussion: Stratifying the Care of Bladder Cancer: From Bench to Bedside and Back Best Abstract: PI-01: Progression from Non-Muscle Invasive Bladder Cancer (NMIBC) to Muscle Invasion is Associated with Lower Response Rates to Neoadjuvant Chemotherapy Best Abstract: PI-02: A Systematic Approach to Discussing Active Surveillance to Patients with Low-risk Prostate Cancer Best Abstract: PI-03: A Randomized Study of Intra-Operative Autologous Retropubic Urethral Sling on Urinary Control after Robot Assisted Radical Prostatectomy Best Abstract: PI-04: Surgeon and Hospital Variation in the Costs of Robot-Assisted Radical Prostatectomy in the United States

16SANPLISA-16 16SANPLISA-17 16SANPLISA-18 16SANPLISA-19

16SANPLISA-6 16SANPLISA-7 16SANPLISA-8 16SANPLISA-9 16SANPLIISU-1 16SANPLIISU-4 16SANPLIISU-5 16SANPLISU 16SANPLISU-1 16SANPLISU-10 16SANPLISU-11 16SANPLISU-12 16SANPLISU-13 16SANPLISU-14 16SANPLISU-15 16SANPLISU-16 16SANPLISU-17

AUA AUA

San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA

5/7/16 5/7/16 5/7/16 5/7/16 5/7/16

Live Activity

AUA

San Diego, CA

5/7/16

Live Activity

AUA

San Diego, CA

5/7/16

Live Activity

AUA

San Diego, CA

5/7/16

Live Activity Live Activity Live Activity Live Activity Live Journal of Urology 2015: Year in Review Activity Live Journal of Urology 2015: Top Papers: Female Urology and Stones Activity Journal of Urology 2015: Top Papers: BPH and Erectile Dysfunction Live Activity Live American Board of Urology Update Activity Rising Star Report: The Effect of Gastric Bypass Surgery on Renal Live Function and Metabolism Activity Utilization of Advanced Practice Providers for In-Office and Live In-Operating Room Procedures Activity Live Plenary Total - Sunday Activity Live Highlights: Urologic Oncology Research Activity Live AUA Guideline: Urethral Strictures Activity Journal of Urology Lecture: The Advantages and Pitfalls of Studies Live based on Administrative Databases Activity Live Highlights: Society for Pediatric Urology Program Activity Live Journal of Urology 2015: High Impact Pediatric Articles Activity John Duckett Memorial Lecture: A Tale of Two Testes: The Bilateral Live Impact of a Unilateral Disease Activity Panel Discussion:Staying On Top of Your Game: Honing a Live Well-Rounded Surgeon Activity Critical Discussion: Injection or Intestine: Management of the Hostile Live Neuropathic Bladder Activity State-of-the-Art Lecture: Fertility for Patients with Disorders of Live Sexual Development Activity Live

Best Abstract: PI-05: Ultra-short, Short, Medium and Long-Pulse Laser Lithotripsy Performance Best Abstract: PI-06: Long-term Pudendal Nerve Electrical Stimulation Accelerates Recovery from Stress Incontinence via Increased Neurotrophin Expression and Nerve Regeneration in an Animal Model Critical Discussion: Urethroplasty: Transecting vs. Non-transecting Approaches State-of-the-Art Lecture: Urology and Global Health: Global Circumcision: WHO Cares State-of-the-Art Lecture: Urology and Global Health: World Vasectomy Day Critical Discussion: Stratifying the Care of BPH: From Bench to Bedside and Back

16SANPLISA-5

AUA

Live Activity

16SANPLISA-20

16SANPLISA-4

AUA

AUA

State-of-the-Art Lecture: Lichen Sclerosis

16SANPLISA-3

AUA

Live Activity Live Activity Live Activity

16SANPLISA-2

16SANPLISA-21

Live Activity Live Activity Live Activity Live Activity Live Activity

San Diego, CA San Diego, CA San Diego, CA

5/7/16

AUA

San Diego, CA

5/7/16

AUA

San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego,

5/7/16

AUA AUA

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

5/7/16 5/7/16

5/7/16 5/7/16 5/7/16 5/7/16 5/7/16 5/7/16 5/8/16 5/8/16 5/8/16 5/8/16 5/8/16 5/8/16 5/8/16 5/8/16 5/8/16 5/8/16 5/8/16 5/8/16 5/8/16

5.00

16SANPLISU-2 16SANPLISU-3 16SANPLISU-4 16SANPLISU-5 16SANPLISU-6 16SANPLISU-7 16SANPLISU-8 16SANPLISU-9 16SANPLIM 16SANPLIM-1 16SANPLIM-10 16SANPLIM-11 16SANPLIM-12 16SANPLIM-13 16SANPLIM-14 16SANPLIM-15 16SANPLIM-16 16SANPLIM-17 16SANPLIM-18 16SANPLIM-19 16SANPLIM-2 16SANPLIM-20 16SANPLIM-3 16SANPLIM-4 16SANPLIM-5 16SANPLIM-6 16SANPLIM-7 16SANPLIM-8 16SANPLIM-9 16SANPLIT 16SANPLIT-1 16SANPLIT-10 16SANPLIT-2 16SANPLIT-27

Live Activity Live State-of-the-Art Lecture: Active Surveillance for Prostate Cancer Activity Panel Discussion: Evaluating Elevated PSA after a Negative Biopsy Live Activity Panel Discussion: Screening for Prostate Cancer: Past, Present and Live Future Activity State-of-the-Art Lecture: Lipid and Cholesterol Promotion of Live Prostate Cancer Progression Activity John K. Lattimer Lecture: Erectile Dysfunction: From Bark to Pill to Live Stem Cell and Beyond Activity State-of-the-Art Lecture: Sexual Health after Androgen Deprivation Live Therapy for Prostate Cancer Activity State-of-the-Art Lecture: Female Sexual Dysfunction: FDA and Live Beyond Activity Live Plenary Total - Monday Activity Highlights: Society of Genitourinary Reconstructive Surgeons Live Program Activity Live AUA Guideline: Surgical Management of Renal Calculi Activity Live AUA Guideline: Surgical Management of Ureteral Calculi Activity Urological Association of Asia (UAA) Lecture: Men's Health in Asia Live Activity Live Panel Discussion: What Makes a Better Surgeon? Activity European Association of Urology (EAU) Lecture: The Underactive Live bladder: Where do we stand in 2016? Activity Critical Discussion: Perioperative Preparation of the Geriatric Patient Live Activity PI-LBA 01: Sacral Neuromodulation versus OnabotulinumtoxinA for Live Refractory Overactive Bladder Activity Live PI-LBA 02: Reevaluating PSA testing rates in the PLCO trial Activity Live PI-LBA 03: Testosterone Therapy and Prostate Cancer Risk Activity PI-LBA 04: Hemiablation HIFU for Unilateral Localized Prostate Live Cancer: a Prospective Multicenter Trial Activity Highlights: Society of Urodynamics, Female Pelvic Medicine and Live Urogenital Reconstruction Program Activity PI-LBA 05: Understanding the Sexual Habits of Men Taking Live Medication for Erectile Dysfunction (ED): Survey Results From 7 Activity Countries Live Highlights: Society of Urologic Oncology Program Activity Point-Counterpoint: Testis Cancer Surveillance: Low Dose CT is Live Better Than MRI Activity State-of-the-Art Lecture: Precursors to the Randall Plaque: Novel Live Perspectives on Nephrolithiasis Activity Panel Discussion: NIDDK: MAPPing a Path to a Cure for Chronic Live Pelvic Pain Activity Presidential Address: U.S. Healthcare Reform: Past, Present and Live Future Activity Live Ramon Guiteras Lecture: Cancer Moonshot 2020 Urology Activity Panel Discussion: MESH for POP and SUI: An International Live Perspective Activity Live Plenary Total - Tuesday Activity Live AUA Guideline: Non-muscle Invasive Bladder Cancer Activity Live Complex Cases: Peyronie's Disease Activity Societe Internationale d'Urologie (SIU) Lecture: Image guided Live therapy for Prostate Cancer: Quo vadis? Activity PI-LBA 06: VA CSP#553 Chemotherapy After Prostatectomy (CAP) Live For High Risk Prostate Carcinoma: A Phase III Randomized Study Activity Highlights: Benign Urologic Research

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA

5/8/16 5/8/16 5/8/16 5/8/16 5/8/16 5/8/16 5/8/16 5/8/16 5/9/16

4.25

5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/9/16 5/10/16 5/10/16 5/10/16 5/10/16 5/10/16

4.25

16SANPLIT-28

16SANPLIT-29 16SANPLIT-3 16SANPLIT-30 16SANPLIT-4 16SANPLIT-5 16SANPLIT-6 16SANPLIT-7 16SANPLIT-8 16SANPLIT-9 UPDATESERIES15-38 UPDATESERIES14-2 UPDATESERIES16-5 ETHICSMOD-9 updateseries13-40 UPDATESERIES16-9 UPDATESERIES16-8 UPDATESERIES14-13 UPDATESERIES14-1 UPDATESERIES16-4 UPDATESERIES15-24 UPDATESERIES16-10 RCC151ONL-13 UPDATESERIES15-15 UPDATESERIES15-14 UPDATESERIES16-18 MRFUSIONPREREQ 2015AMHLOAB UPDATESERIES16-26 16NESAM PCA151ONL-1 RCC161ONL-16 UPDATESERIES14-32

PI-LBA 07: The Development and Clinical Validation of a High Sensitivity Urine biomarker test for the Determination of Recurrence in Urothelial Carcinoma Patients PI-LBA 08: Preliminary Assessment of a Validated Urine Exosome Assay (ExDx Prostate (IntelliScore) for Predicting Biochemical Recurrence Post-Prostatectomy Critical Discussion: Advanced Testing for Male Infertility: Age-specific Guidelines? PI-LBA 09: IsoPSA: Initial Clinical Performance Evaluation of a Novel Structure-Based Biomarker For Prostate Cancer in a Multicenter Prospective Trial for Gleason = 7 Point-Counterpoint: Is There a Role for Nutraceuticals in Male Infertility? Panel Discussion: Stratifying Care of the Small Renal Mass: From Bench to Bedside and Back

Live Activity

AUA

San Diego, CA

5/10/16

Live Activity

AUA

San Diego, CA

5/10/16

Live Activity

AUA

San Diego, CA

5/10/16

Live Activity

AUA

San Diego, CA

5/10/16

Live Activity Live Activity Live Complex Cases: Intraoperative Consult for Ureteral Injury Activity Complex Cases: Bladder Cancer: High Grade Superficial TCCA Live when there is no BCG or BCG Fails Activity Live Complex Cases: Stones: 15 mm Lower Pole Stone Activity Live Complex Cases: Chronic Orchialgia Activity Enduring Evaluation and Management of Nocturia Material Salvage Therapy after Primary Non-Surgical Therapy for Prostate Enduring Cancer Material Enduring Introductory Statistics in Urology Research Material Enduring Ethics Module 9: Competent Care Material Enduring Surgical Care Improvement Project as Applied to Urology Material Enduring Female Reproductive Medicine for the Urologist Material Effects of Dietary and Supplemental Calcium and Vitamin D on Enduring Stone Disease Material Enduring Management of Urological Conditions during Pregnancy Material Enduring Update Series 2014 Volume 33 Lesson 1: Renal Trauma Material Enduring Hematuria in Children Material Enduring Preventive Medicine Counseling in the Urologist’s Office Material Enduring Initial Evaluation and Management of Acute Urinary Retention Material Enduring 2015 Recertification (MOC) Webcast: Infections Material Where Does Shock Wave Lithotripsy Fit in 2015? Technology, Enduring Patient Selection and Techniques Material Enduring Cryptorchidism Material Enduring Male Infertility and Overall Health Material Enduring MR Fusion Guided Prostate Biopsy Course Pre-Requisite Material Enduring 2015 Annual Meeting Highlight: Overactive Bladder (OAB) Material Enduring Pearls and Pitfalls in Bladder Cancer Pathology Material Live Northeastern Section 2016 Annual Meeting Activity Establishing an Advanced Prostate Cancer Clinic Webcast Session 1: Enduring How to Get Started Material 2016 Recertification (MOC) Webcast: Stone Disease / Benign Upper Enduring Tract Conditions Material Enduring Promoting Professionalism in Urology Material

San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA San Diego, CA Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD

5/10/16

AUA AUA

AUA AUA AUA AUA AUA AUA AUA

5/10/16 5/10/16 5/10/16 5/10/16 5/10/16 5/12/16

1.00

5/14/16

1.00

6/17/16

1.00

6/28/16

0.50

6/29/16

1.00

7/4/16

1.00

7/11/16

1.00

7/12/16

1.00

7/26/16

1.00

8/4/16

1.00

8/7/16

1.00

8/24/16

1.00

Internet

8/25/16

1.00

Linthicum, MD Linthicum, MD Linthicum, MD

8/29/16

1.00

9/5/16

1.00

9/12/16

1.00

9/19/16

3.75

Linthicum, MD Linthicum, MD

9/22/16

1.25

9/23/16

1.00

AUA

Buffalo, NY

10/1/16

17.25

AUA

Internet

10/4/16

2.00

AUA

Internet

10/8/16

1.00

AUA

Linthicum, MD

10/15/16

1.00

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

AUA AUA AUA AUA AUA

UPDATESERIES16-30 Genetics in Urology: A Urologist’s Guide to the Genetic Revolution UPDATESERIES16-21 Asymptomatic Bacteriuria UPDATESERIES14-15 Pathophysiology and Management of Infection Stones UPDATESERIES15-35 High Grade Prostatic Intraepithelial Neoplasia: Natural History and Management JU16-8

The Journal of Urology Vol. 196(8), August 2016

UPDATESERIES15-7

Evaluation and Treatment of the Adolescent Varicocele

UPDATESERIES16-1

The Role of Social Media in Urology

UPDATESERIES16-36 Perioperative Management of the Older Urology Patient UPDATESERIES14-4

Endogenous Hormone Correction as Medical Treatment of Male Infertility

UPDATESERIES16-23 Diagnosis and Management of Angiomyolipoma UPDATESERIES14-19 Assessment and Management of an Adrenal Mass in Urological Practice Sub Total for 2016 AMA PRA Category 1 Credits™:

Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material

Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD

10/18/16

1.00

10/19/16

1.00

10/24/16

1.00

10/27/16

1.00

AUA

Internet

10/28/16

2.00

AUA

Linthicum, MD Linthicum, MD Linthicum, MD Linithicum, MD Linthicum, MD Linthicum, MD

11/13/16

1.00

11/18/16

1.00

12/10/16

1.00

12/12/16

1.00

12/24/16

1.00

12/28/16

1.00

AUA AUA AUA AUA

AUA AUA AUA AUA AUA

90.50

Year: 2015 Program Code

Program

UPDATESERIES15-4

Natural Medicine for Early Prostate Cancer

updateseries13-8

Management of Renal Cell Carcinoma with Vena Caval/Atrial Extension

updateseries13-23

Assessment of Renal Function

15NOLAFR1

Urologic Oncology Research Symposium

15NOLASSPU1

Society for Pediatric Urology - Friday

15NOLAFR4

Plenary II - Second Opinion Cases

15NOLAFRPELV

The Science of Female Pelvic Health

15NOLAFR6

Urologic Care for the Allied Health Professional

15NOLAPLIS

Plenary - Sunday

15NOLAPLIS-1

Welcome and Announcements

15NOLAPLIS-10

State-of-the-Art Lecture: Surgical Management of A

15NOLAPLIS-11

AUA Guideline: Peyronie's Disease

15NOLAPLIS-12

Highlights: Society of Pediatric Urology (SPU) Pro

15NOLAPLIS-13

John Duckett Memorial Lecture: Minimally Invasive

15NOLAPLIS-14

Panel Discussion: Simulation in Surgical Education

15NOLAPLIS-15

State-of-the-Art Lecture: Modern Management of the

15NOLAPLIS-16

Point-Counterpoint: Recent Randomized Controlled T

15NOLAPLIS-17

Best Abstract: PI-01: Rectourethral Fistulas Secondary to Prostate Cancer Treatment: Management and Outcomes Best Abstract: PI-02: Age and Obesity Promote Methylation and Suppression of 5-Alpha Reductase 2–-Implications for Personalized Therapy in BPH Best Abstract: PI-03: Scrotal Ultrasound for Pain: Low Frequency of

15NOLAPLIS-18

Learning Format

Accredited Provider

Enduring Material Enduring Material Enduring Material Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity

AUA

Live Activity Live

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

AMA PRA Category 1 Credits™

Location

Date

Linthicum, MD Linthicum, MD Linthicum, MD New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA

2/13/15

1.00

4/20/15

1.00

5/7/15

1.00

5/15/15

8.00

5/15/15

7.50

5/16/15

4.00

5/16/15

4.00

5/17/15

7.75

5/17/15

4.50

New Orleans, LA New

5/17/15 5/17/15 5/17/15 5/17/15 5/17/15 5/17/15 5/17/15 5/17/15 5/17/15 5/17/15

15NOLAPLIS-19

Best Abstract: PI-03: Scrotal Ultrasound for Pain: Low Frequency of Absolute Surgical Indications

15NOLAPLIS-2

Highlights: Oncology Research Program

15NOLAPLIS-3

Highlights: Research in Benign Diseases Program

15NOLAPLIS-4

State-of-the-Art Lecture: Hormone Therapy for Men

15NOLAPLIS-5

Critical Discussion: Fertility Preservation in Can

15NOLAPLIS-6

Panel Discussion: Optimal Management of Ischemic P

15NOLAPLIS-7

State-of-the-Art Lecture: PDE5 Inhibitors Side Aff

15NOLAPLIS-8

John K. Lattimer Lecture: Integrating the Digital

15NOLAPLIS-9

State-of-the-Art Lecture: Management of Urinary In

15NOLAPLIM

Plenary I - Monday

15NOLAPLIM-1

Highlights: The Science of Female Pelvic Health

15NOLAPLIM-10

State-of-the-Art Lecture: Urological Association o

15NOLAPLIM-11

State-of-the-Art Lecture: Pathophysiology and Mana

15NOLAPLIM-12

State-of-the-Art Lecture: Antibiotic Stewardship

15NOLAPLIM-13

State-of-the-Art Lecture: The Beers Criteria for P

15NOLAPLIM-14

Panel Discussion: Special Considerations for Treat

15NOLAPLIM-15

AUA Guideline: Interstitial Cystitis Guideline Ame

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA

5/17/15 5/17/15 5/17/15 5/17/15 5/17/15 5/17/15 5/17/15 5/17/15 5/17/15 5/18/15 5/18/15 5/18/15 5/18/15 5/18/15 5/18/15 5/18/15 5/18/15

Best Abstract: PI-04: Durable Reductions in Urinary Incontinence with Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of 3.5-Year Study Best Abstract: PI-05: Is Retropubic Mid-urethral Sling Safe and Effective for Patients with Valsalva Voiding? State-of-the-Art Lecture: Catheter Associated Urinary Tract Infections: Definitions and Significance in the Urologic Patient. An AUA White Paper

Live Activity

AUA

New Orleans, LA

5/18/15

Live Activity

AUA

New Orleans, LA

5/18/15

Live Activity

AUA

New Orleans, LA

5/18/15

15NOLAPLIM-2

State-of-the-Art Lecture: Urodynamic Mismatch: Wha

15NOLAPLIM-3

Point-Counterpoint: Refractory Overactive Bladder

15NOLAPLIM-4

Point-Counterpoint: Occult SUI: What have Clinical

15NOLAPLIM-5

Presidential Address: Learning from Yesterday, Liv

15NOLAPLIM-6

Guiteras Lecture: Two Decades of Innovation in Min

15NOLAPLIM-7

Critical Discussion: Renal Ureteroscopy for Stones

15NOLAPLIM-8

Panel Discussion: Minimally Invasive Ureteral Reco

15NOLAPLIM-9

AUA Guideline Update: Castration-Resistant Prostat

15NOLAPLIIT-5

State-of-the-Art Lecture: Ultrasound Propulsion of

15NOLAPLIT

Plenary I - Tuesday

15NOLAPLIT-1

State-of-the-Art Lecture: Contemporary Update on T

15NOLAPLIT-10

Panel Discussion - Artificial Urinary Sphincter

15NOLAPLIT-11

Panel Discussion - Percutaneous Surgery for Stones

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live

15NOLAPLIM-16 15NOLAPLIM-17 15NOLAPLIM-18

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New

4.50

5/18/15 5/18/15 5/18/15 5/18/15 5/18/15 5/18/15 5/18/15 5/18/15 5/19/15 5/19/15 5/19/15 5/19/15 5/19/15

4.50

15NOLAPLIT-12

Panel Discussion - Cystectomy for Invasive Bladder

15NOLAPLIT-13

Panel Discussion - Continent Diversions

15NOLAPLIT-14

Panel Discussion - Screening for Prostate Cancer

15NOLAPLIT-15

Panel Discussion - Robotic Prostatectomy

15NOLAPLIT-16

Panel Discussion - Changes in Prostate Grading

15NOLAPLIT-17

Panel Discussion - Partial Nephrectomy

15NOLAPLIT-2

State-of-the-Art Lecture: Bacillus Calmette-Guerin

15NOLAPLIT-3

Societe Internationale di Urologie (SIU) Lecture:

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity

AUA AUA AUA AUA AUA AUA AUA AUA

New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA

5/19/15 5/19/15 5/19/15 5/19/15 5/19/15 5/19/15 5/19/15 5/19/15

Best Abstract: PI-06: TCF21, A Novel Metastasis Suppressor, Promotes the Acquisition of a Luminal Phenotype in Human Bladder Cancer Best Abstract: PI-07: A Transplant-Based Surgical Approach May Improve Postoperative Complications in Cases of Renal Cell Carcinoma and Tumor Thrombus Best Abstract: PI-08: Combining Urine PCA3 and TMPRSS2:Erg Tests to Refine Prostate Cancer Detection – Validation Study and Health Economic Analysis Best Abstract: PI-09: Preclinical Testing of Small Molecule HIF2&a Inhibitor in Zebrafish and Mouse Models of VHL-deficient Renal Cell Carcinoma Best Abstract: PI-10: Declining Rates of Retroperitoneal Lymph Node Dissection for Stage I Non-Seminomatous Germ Cell Tumors: Results from the National Cancer Database

Live Activity

AUA

New Orleans, LA

5/19/15

Live Activity

AUA

New Orleans, LA

5/19/15

Live Activity

AUA

New Orleans, LA

5/19/15

Live Activity

AUA

New Orleans, LA

5/19/15

Live Activity

AUA

New Orleans, LA

5/19/15

15NOLAPLIT-4

Point-Counterpoint: Neoadjuvant Chemotherapy for M

15NOLAPLIT-5

State-of-the-Art Lecture: Rapamycin Improves T Cel

15NOLAPLIT-6

State-of-the-Art Lecture: Management of Radiation

15NOLAPLIT-7

Panel Discussion: Chemotherapy vs. RPLND for Stage

15NOLAPLIT-8

State-of-the Art Lecture: Vasectomy and Prostate C

15NOLAPLIT-9

Panel Discussion - Mid Urethral Sling

updateseries13-11

Robotic Partial Nephrectomy

UPDATESERIES15-6

Bioethics and Regulatory Compliance in Urological Clinical Trials and Research

JU14-4

The Journal of Urology Vol. 191 (4), April 2014

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Live Activity Live Activity

15NOLAPLIT-33

15NOLAPLIT-34

15NOLAPLIT-35

15NOLAPLIT-36

15NOLAPLIT-37

UPDATESERIES15-18 Genitourinary Trauma UPDATESERIES14-5

Optimizing Outcomes and Patient Satisfaction with Penile Implants

updateseries13-37

Imaging in the Management of Ureteral Calculi

ju13v189/190-11

The Journal of Urology Vol. 190(5), November 2013

updateseries13-20

Assessing and Improving the Quality of Urological Care

RCC151ONL-19

2015 Recertification (MOC) Webcast: Mock Exam 2

RCC151ONL-5

2015 Recertification (MOC) Webcast: Female Urology

RCC151ONL-2

2015 Recertification (MOC) Webcast: Erectile Dysfunction/Infertility/Hormone Replacement

15NESAM

Northeastern Section 2015 Annual Meeting

15NESAM

Northeastern Section 2015 Annual Meeting

New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA New Orleans, LA Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD

5/19/15

AUA

AUA AUA AUA AUA AUA AUA AUA

5/19/15 5/19/15 5/19/15 5/19/15 5/19/15 6/10/15

1.00

6/25/15

1.00

6/28/15

2.00

7/9/15

1.00

7/30/15

1.00

8/1/15

1.00

9/9/15

2.00

9/10/15

1.00

Internet

10/19/15

0.25

AUA

Internet

10/20/15

1.25

AUA

Internet

10/20/15

1.50

AUA

Quebec, Canada Quebec, Canada

10/31/15

18.25

10/31/15

18.25

AUA AUA AUA AUA AUA AUA AUA

AUA

Enduring Material UPDATESERIES15-33 Cytoreductive Nephrectomy in the Age of Targeted Systemic Therapy Enduring Material Renal Abscess, Xanthogranulomatous Pyelonephritis and Renal Enduring UPDATESERIES14-36 Tuberculosis Material Clinical Problem Solving (CPS) Protocol: Adjuvant and Salvage Enduring CPS15-6 Radiotherapy After Prostatectomy Material Clinical Problem Solving (CPS) Protocol: Asymptomatic Enduring CPS15-8 Microhematuria Material Enduring UPDATESERIES15-11 Prostatic Gizmos and Treatments for BPH: Past, Present and Future Material Sub Total for 2015 AMA PRA Category 1 Credits™: UPDATESERIES15-31 Chronic Pelvic Pain Syndrome in Men

Linthicum, MD Linthicum, MD Linthicum, MD

11/8/15

1.00

11/29/15

1.00

11/29/15

1.00

AUA

Internet

12/1/15

0.50

AUA

Internet

12/2/15

0.50

AUA

Linthicum, MD

12/13/15

1.00

AUA AUA AUA

102.25

Year: 2014 Program Code

Program

14ORLMP01

Urodynamics/Incontinence/Female Urology: Basic Res

14ORLMP02

General & Epidemiological Trends & Socieconomics:

14ORLMP03

Trauma/Reconstruction: Trauma & Reconstructive Sur

14ORLMP04

Urodynamics/Incontinence/Female Urology: Basic Res

14ORLPOD01

Adrenal

14ORLPOD02

General & Epidemiological Trends & Socioeconomics:

14ORLPOD03

Trauma/Reconstruction: Trauma & Reconstructive Sur

14ORLPOD04

Imaging/Radiology I

14ORLMP05

Urinary Diversion: Bladder Reconstruction, Augment

14ORLMP07

Imaging/Radiology II

14ORLMP09

Trauma/Reconstruction: Trauma & Reconstructive Sur

14ORLMP12

Imaging/Radiology III

14ORLPLIS-7

State-of-the-Art Lecture: Radiation Induced ED

14ORLPLIS-8

State-of-the-Art Lecture: The Adverse Effects of C

14ORLPLIS-9

State-of-the-Art Lecture: Peyronies Disease: Ratio

14ORLPLS

Plenary - Sunday

14ORLPLIIM-1

European Association of Urology (EAU) Lecture: Bet

14ORLPLIIM-2

State-of-the-Art Lecture: Role of Asymptomatic Bac

14ORLPLIIM-3

State-of-the-Art Lecture: Role of the Gastrointest

14ORLPLM

Plenary - Monday

14ORLPOD18

Bladder Cancer: Invasive I

14ORLPOD19

Prostate Cancer: Detection & Screening I

14ORLPLIIT-1

State-of-the-Art Lecture: Standardized Nomenclatur

14ORLPLIIT-2

Panel Discussion: Prostate Cancer and Renal Transp

14ORLPLIIT-3

Point-Counterpoint: Using Donors with Hypertension

AMA PRA Category 1 Credits™

Learning Format

Accredited Provider

Location

Date

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity

AUA

Orlando, FL

5/16/14

2.00

AUA

Orlando, FL

5/16/14

2.00

AUA

Orlando, FL

5/16/14

2.00

AUA

Orlando, FL

5/16/14

2.00

AUA

Orlando, FL

5/16/14

2.00

AUA

Orlando, FL

5/16/14

2.00

AUA

Orlando, FL

5/16/14

2.00

AUA

Orlando, FL

5/16/14

1.00

AUA

Orlando, FL

5/17/14

2.00

AUA

Orlando, FL

5/17/14

1.00

AUA

Orlando, FL

5/17/14

2.00

AUA

Orlando, FL

5/17/14

0.50

AUA

Orlando, FL

5/18/14

AUA

Orlando, FL

5/18/14

AUA

Orlando, FL

5/18/14

AUA

Orlando, FL

5/18/14

AUA

Orlando, FL

5/19/14

AUA

Orlando, FL

5/19/14

AUA

Orlando, FL

5/19/14

AUA

Orlando, FL

5/19/14

1.00

AUA

Orlando, FL

5/19/14

2.00

AUA

Orlando, FL

5/19/14

2.00

AUA

Orlando, FL

5/20/14

AUA

Orlando, FL

5/20/14

AUA

Orlando, FL

5/20/14

1.00

14ORLPLIIT-4

State-of-the-Art Lecture: Radiation Risk and Moder

14ORLPLIT-1

Best Abstract 6: Does treatment strategy for local

14ORLPLIT-10

Panel Discussion: Tests to Distinguish Aggressive

14ORLPLIT-11

State-of-the-Art Lecture: Evidence-based vs. Conse

14ORLPLIT-12

Point-Counterpoint: HIFU for Localized Prostate Ca

14ORLPLIT-13

State-of-the-Art Lecture: Clinical Implications of

14ORLPLIT-3

Best Abstract 8: Mortality Benefit of Screening Me

14ORLPLIT-4

State-of-the-Art Lecture: Bladder Cancer - Prognos

14ORLPLIT-5

State-of-the-Art Lecture: PET Imaging for Localizi

14ORLPLIT-6

Societe Internationale d'Urologie (SIU) Lecture: P

14ORLPLT

Plenary - Tuesday

14ORLPLIW-10

Critical Discussion: Does MRI Improve Outcomes in

14ORLPLIW-11

Take Home Message - Prostate Cancer

14ORLPLIW-12

Take Home Message - Basic Science Research

14ORLPLIW-13

Take Home Message - Infection/Inflammation

14ORLPLIW-14

Take Home Message - Infertility/Andrology

14ORLPLIW-15

Take Home Message - Stone Disease/Endourology

14ORLPLIW-16

Take Home Message - Transplantation/Vascular Surge

14ORLPLIW-17

Take Home Message - Penile, Testis and Urethral Ca

14ORLPLIW-18

Take Home Message - Trauma/Reconstruction/Diversio

14ORLPLIW-19

Take Home Message - Sexual Function/Dysfunction

14ORLPLIW-20

Take Home Message - Female Urology/Incontinence/Ur

14ORLPLIW-21

Take Home Message - BPH/LUTS

14ORLPLIW-22

Take Home Message - Minimally Invasive Surgery (La

14ORLPLIW-23

Take Home Message - Outcomes Analysis

14ORLPLIW-24

Take Home Message - Kidney Cancer

14ORLPLIW-25

Take Home Message - Bladder Cancer

14ORLPLIW-3

Best Abstract 11: Nephron Sparing Techniques Indep

14ORLPLIW-4

Best Abstract 12: Connecttm - A Pilot Study for th

14ORLPLIW-5

State-of-the-Art Lecture: Health Policy Update

14ORLPLIW-6

State-of-the-Art Lecture: Quality of Performance o

14ORLPLIW-7

State-of-the-Art Lecture: Active Surveillance: Con

14ORLPLIW-8

Award Winning Video: Completely Intracorporeal Rob

14ORLPLIW-9

Award Winning Video: Endockscope: Bridging Endosco

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity

AUA

Orlando, FL

5/20/14

AUA

Orlando, FL

5/20/14

AUA

Orlando, FL

5/20/14

AUA

Orlando, FL

5/20/14

AUA

Orlando, FL

5/20/14

AUA

Orlando, FL

5/20/14

AUA

Orlando, FL

5/20/14

AUA

Orlando, FL

5/20/14

AUA

Orlando, FL

5/20/14

AUA

Orlando, FL

5/20/14

AUA

Orlando, FL

5/20/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

AUA

Orlando, FL

5/21/14

3.00

14ORLPLW

Plenary - Wednesday

UPDATESERIES14-12 Imaging Contrast Media Reactions and Management updateseries13-1

Antimicrobial Prophylaxis for Transrectal Ultrasound Biopsy

UPDATESERIES14-23 Contemporary Prostate Imaging and Applications for Diagnosis and Staging of Prostate Cancer RCC141

Recertification (MOC) Review Course

JU14-6

The Journal of Urology Vol. 190(6), June 2014

UPDATESERIES14-35 Contemporary Management of Posterior Urethral Stenosis Non-Cardiac Factors for Preoperative Risk Assessment of Patients Undergoing Genitourinary Surgery Sub Total for 2014 AMA PRA Category 1 Credits™: updateseries12-5

Live Activity Enduring Material Enduring Material Enduring Material Live Activity Enduring Material Enduring Material Enduring Material

AUA

Orlando, FL

5/21/14

4.00

AUA

Linthicum, MD Linthicum, MD Linthicum, MD

6/18/14

1.00

7/23/14

1.00

9/5/14

1.00

10/8/14

1.00

11/3/14

2.00

11/4/14

1.00

12/31/14

1.00

AUA AUA AUA AUA AUA AUA

Linthicum, MD Linthicum, MD Linthicum, MD

41.50

Year: 2013 Program Code

Program

Learning Format

Accredited Provider

Location

13SANPLI-3

Best Abstract-Concordance in Molecular Marker Status between Bladder Tumors at Time of Transurethral Resection and Subsequent Ra

Live Activity

AUA

Linthicum, MD

13SANPLIIM-1

MALE LUTS: Completing the Paradigm Shift

13SANPLIIM-2 13SANPLIIM-3 13SANPLIIM-4 13SANPLIIM-5 13SANPLIIM-6 13SANPLIIS-1 13SANPLIIS-2 13SANPLIIS-3 13SANPLIIS-4 13SANPLIIS-5 13SANPLIIT-2 13SANPLIIT-4 13SANPLIM-1 13SANPLIM-12 13SANPLIM-2 13SANPLIM-3 13SANPLIM-4 13SANPLIM-5 13SANPLIM-6 13SANPLIS-1

Live Activity Live Occult SUI, What do the Trials Teach Us? Activity Surgical Treatment for Retention Post Sling is Early vs. Late Release: Live Technical Differences & Outcomes Activity Live Detection of Prostate Cancer Activity Live Castration Resistant Prostate Cancer Activity Live Late Breaking News Activity Live Health Policy Update Activity Live ABU Update Activity Live Sampling of Prostate Biopsies Activity Live Health Care Reform: Hospital CEO Point of View Activity Live ICUD Panel Update: Anti-Coagulation and Anti-Platelet Therapy Activity When Non-Transplant Urologists Consult on Renal Transplant Live Patients: Prostate Cancer and Oncologic Conditions, Repair Of Activity Uretera Live Using Ultrasound to Move Stones Activity Best Abstract-Comparison of Tissue Injury from a Novel Technique Live of Focused Ultrasonic Propulsion of Kidney Stones versus Extrac Activity Live Critical Discussion-Latrogenic Ureteral Injury Management Activity Best Abstract-Increased Excitability of Bladder Afferent Neurons Live Associated with Reduced Expression of Kv1.4 &[alpha]-subunit in Activity Best Abstract-Changes in Pelvic Organ Prolapse Surgery Over the Live Last Decade Among US Urologists Activity Live Critical Discussion-Impact of Kidney Stones on Renal Function Activity State of the Art-Using Imaging to Select and Predict Operative Live Results in Urolithiasis Activity Video Debate-Management of Staghorn Stone Patient PCNL vs. Live Laparoscopic Anatrophic Nephrolithotomy Activity Live Highlights Oncology Research Activity

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD

Date

AMA PRA Category 1 Credits™

6/1/13

0.25

6/1/13

0.25

6/1/13

0.50

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.50

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

13SANPLIS-1 13SANPLIS-11 13SANPLIS-2 13SANPLIS-2 13SANPLIS-3 13SANPLIS-3 13SANPLIS-4 13SANPLIS-4 13SANPLIS-5 13SANPLIS-6 13SANPLIS-7 13SANPLIS-8 13SANPLIT-1 13SANPLIT-10 13SANPLIT-11 13SANPLIT-12 13SANPLIT-13 13SANPLIT-14 13SANPLIT-15 13SANPLIT-2 13SANPLIT-3 13SANPLIT-4 13SANPLIT-5 13SANPLIT-6 13SANPLIT-7 13SANPLIT-8 13SANPLIT-9 13SANPLITHM-1 13SANPLITHM-2 13SANPLITHM-3 13SANPLITHM-4 13SANPLITHM-5 13SANPLITHM-7 13SANPLITHM-9

Live Activity Live Panel Discussion-Hormones, the Environment and GU Anomalies Activity Live Highlights Research in Benign Disease Activity Live Highlights Research in Benign Disease Activity Best Abstract 1 - Testosterone Supplementation Does Not Worsen Live Lower Urinary Tract Symptoms Activity Best Abstract 1 - Testosterone Supplementation Does Not Worsen Live Lower Urinary Tract Symptoms Activity Live Exogenous Testosterone: A Preventable Cause of Male Infertility Activity Live Exogenous Testosterone: A Preventable Cause of Male Infertility Activity Male Infertility as a Marker of Pediatric, Present and Future Male Live Health: This Generation to the Next Activity Role of Technology in the Future Management of Erectile Live Dysfunction Activity The Urologist Should Perform Cardiac Disease Screening in the Live Management of the Erectile Dysfunction Activity Live Intralesional Collagenase in the Treatment of Peyronie's Disease Activity Best Abstract-Does Increasing the Nodal Yield Improve Outcomes in Live Patients without Nodal Metastasis at Radical Prostatectomy? Activity UAA Lecture-Patient-derived Xenografts as Useful Models for Live Prostate Cancer Research Activity Critical Discussion-Bacteria in Elderly Men and Women with Live Catheters &/or CIC Activity State of the Art Lecture-Medication Use in Geriatric Urological Live Patients: The Updated Beers' Criteria Activity Live Point Counterpoint-Alpha Blocker vs. PDE5i for BPH/LUTS Activity State of the Art Lecture-Retreatment Rate in Ablation Therapy for Live BPH Activity Live State of the Art Lecture-End of Life Discussion Activity Best Abstract-What Should the Role of a Diagnosis of Prostate Live Cancer Be on Listing ESRD Patients for Renal Transplantation? Activity Best Abstract-Critical Assessment of Criteria Used to Identify Men Live Eligible for Active Surveillance of Low-Risk Prostate Activity Live AUA Clinical Guideline-Follow-up Care for Renal Cancer Activity Panel Discussion-Molecular Markers for Risk; Diagnosis and Live Prognosis in Prostate Cancer Activity Live Point-Counterpoint-Should We Treat Low Risk CaP Activity EAU Lecture-High Risk Prostate Cancer: The Best Indication for Live Radical Prostatectomy Activity Live AUA Clinical Guideline-Radiation after Prostatectomy Activity Critical Discussion-Managing Progressive Prostate Cancer: How, Live Who and When Activity Live Takc Home Message -Prostate Cancer Activity Live Take Home Message-Basic Science Research Activity Live Take Home Message-Infection/Inflammation Activity Live Take Home Message-Infertility/Andrology Activity Live Take Home Message-Stone Disease/Endourology Activity Live Take Home Message-Penile, Testis and Urethral Cancer Activity Live Take Home Message-Sexual Function/Dysfunction Activity Live Highlights Oncology Research

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum,

6/1/13

0.25

6/1/13

0.50

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.50

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.50

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.50

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

13SANPLITHM10

Take Home Message-Female Urology/Incontinence/Urodynamics

13SANPLITHM11

Take Home Message-BPH/LUTS

13SANPLITHM14

Take Home Message-Kidney Cancer

13SANPLITHM15

Take Home Message-Bladder Cancer

13SANPLIW-1

Best Abstract-Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients without Prior Panel Discussion-Technical Advances in Doing Nephron Sparing Surgery Best Abstract-Expressed Prostatic Secretions Biomarkers Improve Stratification of National Comprehensive Cancer Network Active S Best Abstract-Concordance in Molecular Marker Status between Bladder Tumors at Time of Transurethral Resection and Subsequent Ra State of the Art Lecture-Radionuclide Therapy of Painful Bone Metastases: Past, Present, Future Panel Discussion-Muscle Invasive Bladder Cancer in Elderly Patients: Therapeutic Considerations

13SANPLIW-14 13SANPLIW-2 13SANPLIW-3 13SANPLIW-5 13SANPLIW-6 13SANPLIW-7

Presidential Address

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity

ASMH13 Men's Health World Congress Sub Total for 2013 AMA PRA Category 1 Credits™:

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD

AUA

6/1/13

0.50

6/1/13

0.50

6/1/13

0.50

6/1/13

0.50

6/1/13

0.25

6/1/13

0.50

6/1/13

0.25

6/1/13

0.25

6/1/13

0.25

6/1/13

0.50

6/1/13

0.25

12/12/13

3.00 22.75

Year: 2012 Program Code

Program

12ATLMP07

Prostate Cancer: Epidemiology and Natural History

12ATLMP07

Prostate Cancer: Epidemiology and Natural History

12ATLMP13

Prostate Cancer: Basic Research II

12ATLMP13

Prostate Cancer: Basic Research II

12ATLMP15

Prostate Cancer: Staging II

12ATLMP15

Prostate Cancer: Staging II

12ATLMP17

Kidney Cancer: Basic Research III

12ATLMP17

Kidney Cancer: Basic Research III

12ATLMP19

Prostate Cancer: Basic Research III

12ATLMP19

Prostate Cancer: Basic Research III

12ATLMP20

Bladder Cancer: Basic Research I

12ATLMP20

Bladder Cancer: Basic Research I

12ATLMP25

Kidney Cancer: Evaluation and Staging II

12ATLMP25

Kidney Cancer: Evaluation and Staging II

12ATLMP31

Bladder Cancer: Basic Research II

12ATLMP31

Bladder Cancer: Basic Research II

12ATLMP36

Bladder Cancer: Basic Research III

12ATLMP36

Bladder Cancer: Basic Research III

12ATLMP38

Kidney Cancer: Localized I

Learning Format

Accredited Provider

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

Location Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD

Date

AMA PRA Category 1 Credits™

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

12ATLMP38

Kidney Cancer: Localized I

12ATLMP41

Urinary Diversion: Bladder Reconstruction, Augment

12ATLMP41

Urinary Diversion: Bladder Reconstruction, Augment

12ATLMP44

Bladder Cancer: Detection and Screening

12ATLMP44

Bladder Cancer: Detection and Screening

12ATLMP45

Kidney Cancer: Localized II

12ATLMP45

Kidney Cancer: Localized II

12ATLMP49

Bladder Cancer: Invasive I

12ATLMP49

Bladder Cancer: Invasive I

12ATLMP54

Technology & Instruments: Surgical Education & Ski

12ATLMP54

Technology & Instruments: Surgical Education & Ski

12ATLMP56

Bladder Cancer: Invasive II

12ATLMP56

Bladder Cancer: Invasive II

12ATLMP61

Bladder Cancer: Invasive III

12ATLMP61

Bladder Cancer: Invasive III

12ATLMP62

Bladder Cancer: Superficial II

12ATLMP62

Bladder Cancer: Superficial II

12ATLMP66

Bladder Cancer: Metastatic Disease/Staging

12ATLMP66

Bladder Cancer: Metastatic Disease/Staging

12ATLMP71

Imaging/Radiology: Uroradiology I

12ATLMP71

Imaging/Radiology: Uroradiology I

12ATLMP72

Prostate Cancer: Detection and Screening IV

12ATLMP72

Prostate Cancer: Detection and Screening IV

12ATLMP75

Imaging/Radiology: Uroradiology II

12ATLMP75

Imaging/Radiology: Uroradiology II

12ATLMP77

Prostate Cancer: Markers II

12ATLMP77

Prostate Cancer: Markers II

12ATLPLM1-04

State-of-the-Art-Lecture: Posterier Urethral Compl

12ATLPLM1-05

Late Breaking News: The Value of Patient Reported

12ATLPLM1-06

AUA Guideline Presentation: OAB

12ATLPLM1-07

Panel Discussion: Vaginal Prolapse Surgery - Mesh

12ATLPLM1-08

State-of-the-Art: Lessons from the UITN and PFDN:

12ATLPLM1-09

AUA Guidelines Presentation: Urodynamics

12ATLPLM1-10

Panel Discussion: Extending the Indications for Mi

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.50

12ATLPLM1-11

Panel Discussion: Influence of Vitamin D and Calci

12ATLPLM1-12

Point-Counterpoint: Is Shock Wave Lithotripsy beco

12ATLPLM1-13

State-of-the-Art Lecture: The Use of Imaging in th

12ATLPLM1-14

Late Breaking News: European Randomized Trial of S

12ATLPLM2-02

State-of-the-Art Lecture: Osteoporosis and Bone He

12ATLPLS1-05

Panel Discussion: The Health Consequences of Hypog

12ATLPLS1-06

Point-Counterpoint: Is there a Need for Penile Vas

12ATLPLS1-07

Late Breaking News: HOXB13 Mutations and Prostate

12ATLPLS1-08

John K. Lattimer Lecture: Targeting the Cancer Epi

12ATLPLS1-09

Critical Discussion: Controversies in the Postnata

12ATLPLS1-10

John Duckett Memorial Lecture: Posterier Urethral

12ATLPLS1-11

Panel Discussion: Open Antireflux Surgery is Outmo

12ATLPLS1-12

State-of-the-Art Lecture: Circumcision and HIV, HP

12ATLPLS1-13

State-of-the-Art Lecture: The Use of Laparoscopy f

12ATLPLT1-02

EAU Lecture: The Role of Surgery in N + M + Prosta

12ATLPLT1-03

State-of-the-Art-Lecture: MicroRNA in Prostate Can

12ATLPLT1-04

Critical Discussion: Future of 5 ARI in the Manage

12ATLPLT1-05

Panel Discussion: Systemic Treatments for Castrate

12ATLPLT1-06

State-of-the-Art-Lecture: Not following Level 1 Ev

12ATLPLT1-07

Point-Counterpoint: Intervention Oncology: Radiolo

12ATLPLT1-08

Rising Stars Report

12ATLPLT1-09

Late Breaking News:Measurement of Urinary Symptoms

12ATLPLT1-11

State-of-the-Art Lecture: Update on New Systematic

12ATLPLT1-12

State-of-the-Art-Lecture: Does Laparoscopy or Hig

12ATLPLT1-13

Video Debate: Management of Apical Dissection in R

12ATLPLT2-01

Panel Discussion: Chronic Ureteral Stenting: Long-

12ATLPLT2-02

Point-Counterpoint: Is Laparoscopy Extinct for Ren

12ATLPLT2-03

State-of-the-Art-Lecture: Penile Reconstructive Su

12ATLPLT2-04

Late Breaking News: UITN ValUE Study

12ATLPLT2-05

Video Debate: Treating the Apex at the Time of Vag

12ATLPLW1-01

Highlights: Bladder/Kidney, Prostate Cancer, Basic

12ATLPLW1-02

AUA Guideline Presentation Evaluation of Microscop

12ATLPLW1-03

Point-Counterpoint: Surgery for BPH-We Need More/L

12ATLPLW1-04

Societe Internationale d'Urologie Lecture (SIU): S

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum,

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.50

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.50

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.50

6/3/12

0.25

6/3/12

0.50

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.50

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.50

6/3/12

0.25

6/3/12

0.50

6/3/12

0.25

12ATLPLW1-05

Presidential Address: Celebrating AUA's 110th Bir

12ATLPLW1-06

State-of-the-Art-Lecture: Antibiotic Prophylaxis f

12ATLPLW1-07

State-of-the-Art-Lecture: The Role of Inflammation

12ATLPLW1-08

Ramon Guiteras Lecture: Searching for the Cure of

12ATLPLW1-09

Panel Discussion: CPPS Management - Optimizing Car

12ATLPLW1-12

Video Debate: Best Technique for Male Sling

12ATLPLW2-01

Point-Counterpoint: Focal Therapy for Prostate Can

12ATLPLW2-02

State-of-the-Art-Lecture: Advances in the Use of I

12ATLPLW2-03

Point-Counterpoint: Penile Rehab Following Prostat

12ATLPLW2-04

State-of-the-Art-Lecture: Sexual Medicine and Card

12ATLPLW2-05

Video Debate: Best Technique to Treat Priapism

12ATLPLW2-06

Take Home Messages - Part 1 Prostate Cancer, Basic

12ATLPLW2-07

Take Home Messages - Part 2 Infertility, Stone Dis

12ATLPLW2-08

Take Home Messages - Part 3 Penile Testis and Uret

12ATLPLW2-09

Take Home Messages - Part 4 Female Urology/Inconti

12ATLPLW2-10

Take Home Messages - Part 5 Outcomes Analysis, Kid

12ATLPOD09

Prostate Cancer: Localized II

12ATLPOD09

Prostate Cancer: Localized II

12ATLPOD14

Prostate Cancer: Advanced I

12ATLPOD14

Prostate Cancer: Advanced I

12ATLPOD15

Prostate Cancer: Localized III

12ATLPOD15

Prostate Cancer: Localized III

12ATLPOD20

Kidney Cancer: Evaluation and Staging III

12ATLPOD20

Kidney Cancer: Evaluation and Staging III

12ATLPOD25

Prostate Cancer: Detection and Screening I

12ATLPOD25

Prostate Cancer: Detection and Screening I

12ATLPOD29

Technology & Instruments: Robotics - Malignant Dis

12ATLPOD29

Technology & Instruments: Robotics - Malignant Dis

12ATLPOD42

Kidney Cancer: Advanced II

12ATLPOD42

Kidney Cancer: Advanced II

12ATLPOD44

Prostate Cancer: Markers I

12ATLPOD44

Prostate Cancer: Markers I

Sub Total for 2012 AMA PRA Category 1 Credits™:

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.50

6/3/12

0.25

6/3/12

0.50

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.25

6/3/12

0.50

6/3/12

0.50

6/3/12

0.50

6/3/12

0.50

6/3/12

0.50

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00

6/3/12

2.00 142.00

Year: 2011 AMA PRA

Program Code

Program

11WASMP02

G & E Trends & Socioeconomics: EBM & Outcomes

11WASMP20

Penis/Testis/Urethra: Benign & Malignant Disease

11WASMP25

Sexual Function/Dysfunction/Andrology: Basic Resea

11WASMP30

Sexual Function/Dysfunction/Andrology: Basic Resea

11WASMP35

Sexual Function/Dysfunction/Andrology: Basic Resea

11WASMP42

Sexual Function/Dysfunction/Andrology: Evaluation

11WASMP43

Urodynamics/Incontinence/Female Urology: Incontine

11WASMP45

Infections/Inflammation of the Genitourinary Tract

11WASMP50

Benign Prostatic Hyperplasia: Basic Research

11WASMP58

Sexual Function/Dysfunction/Andrology: Peyronie's

11WASMP64

Infertility: Physiology, Pathophysiology, Basic Re

11WASPOD01

Adrenal: Surgery/Tumors/Benign & Malignant Disease

11WASPOD03

Prostate Cancer: Staging

11WASPOD04

Trauma/Reconstruction: Trauma & Reconstructive Sur

11WASPOD06

Pediatrics: Andrology - Cryptorchidism & Varicocel

11WASPOD08

Prostate Cancer: Localized

11WASPOD17

Prostate Cancer: Advanced

11WASPOD33

Technology & Instruments: Robotics/Laparoscopy

11WASPOD40

Stone Disease: New Technology/SWL, Ureteroscopic o

11WASPOD43

Sexual Function/Dysfunction/Andrology: Medical and

11WASPOD57

Infertility: Therapy

11WASSS09

SUFU - Society for Urodynamics and Female Urology

11WASSS09

SUFU - Society for Urodynamics and Female Urology

11WASSS20

JONES - R. Frank Jones Urological Society

11WASSS20

JONES - R. Frank Jones Urological Society

11WASSS23

Society for the Study of Male Reproduction

11WASSS23

Society for the Study of Male Reproduction

11WASSS25

SWIU - The Society of Women in Urology

11WASSS25

SWIU - The Society of Women in Urology

UPDATE_SERIES09-19 US28(19)Bulking Agents for Female Stress Urin Sub Total for 2011 AMA PRA Category 1 Credits™:

Learning Format

Accredited Provider

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Enduring Material

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

Location Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD

Date

AMA PRA Category 1 Credits™

6/3/11

2.00

6/3/11

0.25

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

2.00

6/3/11

3.50

6/3/11

3.50

6/3/11

2.50

6/3/11

2.50

6/3/11

3.25

6/3/11

3.25

6/3/11

1.00

6/3/11

1.00

11/3/11

1.00 61.75

Year: 2010 AMA PRA

Program Code

Program

Learning Format

Accredited Provider

10SFOPLM01

Highlights from Saturday and Sunday Sessions: Endo

Live Activity

AUA

10SFOPLM01

Highlights from Saturday and Sunday Sessions: Endo

Live Activity

AUA

10SFOPLM01

Highlights from Saturday and Sunday Sessions: Endo

Live Activity

AUA

10SFOPLM01

Highlights from Saturday and Sunday Sessions: Endo

Live Activity

AUA

10SFOPLM02

State-of-the-Art Lecture: The 3 Ts of Clinical Gu

Live Activity

AUA

10SFOPLM02

State-of-the-Art Lecture: The 3 Ts of Clinical Gu

Live Activity

AUA

10SFOPLM02

State-of-the-Art Lecture: The 3 Ts of Clinical Gu

Live Activity

AUA

10SFOPLM02

State-of-the-Art Lecture: The 3 Ts of Clinical Gu

Live Activity

AUA

10SFOPLM03

Late-Breaking News: Nerve Growth Monoclonal Antib

Live Activity

AUA

10SFOPLM03

Late-Breaking News: Nerve Growth Monoclonal Antib

Live Activity

AUA

10SFOPLM03

Late-Breaking News: Nerve Growth Monoclonal Antib

Live Activity

AUA

10SFOPLM03

Late-Breaking News: Nerve Growth Monoclonal Antib

Live Activity

AUA

10SFOPLM04

Panel Discussion: 60 Years of Progress at the NIDD

Live Activity

AUA

10SFOPLM04

Panel Discussion: 60 Years of Progress at the NIDD

Live Activity

AUA

10SFOPLM04

Panel Discussion: 60 Years of Progress at the NIDD

Live Activity

AUA

10SFOPLM04

Panel Discussion: 60 Years of Progress at the NIDD

Live Activity

AUA

10SFOPLM05

AUA Guideline Presentation: Stress Incontinence Su

Live Activity

AUA

10SFOPLM05

AUA Guideline Presentation: Stress Incontinence Su

Live Activity

AUA

10SFOPLM05

AUA Guideline Presentation: Stress Incontinence Su

Live Activity

AUA

10SFOPLM05

AUA Guideline Presentation: Stress Incontinence Su

Live Activity

AUA

10SFOPLM06

Late-Breaking News: Outcomes of the TOMUS Trial -M

Live Activity

AUA

10SFOPLM06

Late-Breaking News: Outcomes of the TOMUS Trial -M

Live Activity

AUA

10SFOPLM06

Late-Breaking News: Outcomes of the TOMUS Trial -M

Live Activity

AUA

Location San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA

Date

AMA PRA Category 1 Credits™

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

10SFOPLM06

Late-Breaking News: Outcomes of the TOMUS Trial -M

Live Activity

AUA

10SFOPLM07

Panel Discussion: Painful Bladder Syndrome: What H

Live Activity

AUA

10SFOPLM07

Panel Discussion: Painful Bladder Syndrome: What H

Live Activity

AUA

10SFOPLM07

Panel Discussion: Painful Bladder Syndrome: What H

Live Activity

AUA

10SFOPLM07

Panel Discussion: Painful Bladder Syndrome: What H

Live Activity

AUA

10SFOPLM08

Late Breaking News: The Core Curriculum for Urolo

Live Activity

AUA

10SFOPLM08

Late Breaking News: The Core Curriculum for Urolo

Live Activity

AUA

10SFOPLM08

Late Breaking News: The Core Curriculum for Urolo

Live Activity

AUA

10SFOPLM08

Late Breaking News: The Core Curriculum for Urolo

Live Activity

AUA

10SFOPLM09

AUA Guideline Presentation: Interstitial Cystitis/

Live Activity

AUA

10SFOPLM09

AUA Guideline Presentation: Interstitial Cystitis/

Live Activity

AUA

10SFOPLM09

AUA Guideline Presentation: Interstitial Cystitis/

Live Activity

AUA

10SFOPLM10

Point-Counterpoint Debate: Intrinsic Sphincter Def

Live Activity

AUA

10SFOPLM10

Point-Counterpoint Debate: Intrinsic Sphincter Def

Live Activity

AUA

10SFOPLM10

Point-Counterpoint Debate: Intrinsic Sphincter Def

Live Activity

AUA

10SFOPLM10

Point-Counterpoint Debate: Intrinsic Sphincter Def

Live Activity

AUA

10SFOPLM11

Late Breaking News: Long Term Results from the E-

Live Activity

AUA

10SFOPLM11

Late Breaking News: Long Term Results from the E-

Live Activity

AUA

10SFOPLM11

Late Breaking News: Long Term Results from the E-

Live Activity

AUA

10SFOPLM11

Late Breaking News: Long Term Results from the E-

Live Activity

AUA

10SFOPLM12

State-of-the-Art Lecture: Robotics for Female Pel

Live Activity

AUA

10SFOPLM12

State-of-the-Art Lecture: Robotics for Female Pel

Live Activity

AUA

10SFOPLM12

State-of-the-Art Lecture: Robotics for Female Pel

Live Activity

AUA

10SFOPLM12

State-of-the-Art Lecture: Robotics for Female Pel

Live Activity

AUA

San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA

6/3/10

0.25

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

10SFOPLM13

Urologic Association of Asia (UAA) Lecture: Chris

Live Activity

AUA

10SFOPLM13

Urologic Association of Asia (UAA) Lecture: Chris

Live Activity

AUA

10SFOPLM13

Urologic Association of Asia (UAA) Lecture: Chris

Live Activity

AUA

10SFOPLM13

Urologic Association of Asia (UAA) Lecture: Chris

Live Activity

AUA

10SFOPLM14

State-of-the-Art Lecture: Urologic Malignancies a

Live Activity

AUA

10SFOPLM14

State-of-the-Art Lecture: Urologic Malignancies a

Live Activity

AUA

10SFOPLM14

State-of-the-Art Lecture: Urologic Malignancies a

Live Activity

AUA

10SFOPLM14

State-of-the-Art Lecture: Urologic Malignancies a

Live Activity

AUA

10SFOPLS01

Late-Breaking News From the World Congress of Pedi

Live Activity

AUA

10SFOPLS02

Panel Discussion: Update on Reflux and UTIs

Live Activity

AUA

10SFOPLS02

Panel Discussion: Update on Reflux and UTIs

Live Activity

AUA

10SFOPLS02

Panel Discussion: Update on Reflux and UTIs

Live Activity

AUA

10SFOPLS03

John Duckett Memorial Lecture: Howard M. Snyder II

Live Activity

AUA

10SFOPLS03

John Duckett Memorial Lecture: Howard M. Snyder II

Live Activity

AUA

10SFOPLS03

John Duckett Memorial Lecture: Howard M. Snyder II

Live Activity

AUA

10SFOPLS04

Panel Discussion The Management of Ureteroceles

Live Activity

AUA

10SFOPLS04

Panel Discussion The Management of Ureteroceles

Live Activity

AUA

10SFOPLS04

Panel Discussion The Management of Ureteroceles

Live Activity

AUA

10SFOPLS05

John K. Lattimer Lecture - Michael R. Freeman, PhD

Live Activity

AUA

10SFOPLS05

John K. Lattimer Lecture - Michael R. Freeman, PhD

Live Activity

AUA

10SFOPLS05

John K. Lattimer Lecture - Michael R. Freeman, PhD

Live Activity

AUA

10SFOPLS06

AUA Health Policy - Steven M. Schlossber, MD Cha

Live Activity

AUA

10SFOPLS06

AUA Health Policy - Steven M. Schlossber, MD Cha

Live Activity

AUA

10SFOPLS06

AUA Health Policy - Steven M. Schlossber, MD Cha

Live Activity

AUA

San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.75

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

10SFOPLS07

American Board of Urology Update - William D. Stee

Live Activity

AUA

10SFOPLS07

American Board of Urology Update - William D. Stee

Live Activity

AUA

10SFOPLS07

American Board of Urology Update - William D. Stee

Live Activity

AUA

10SFOPLS08

Critical Discussion: Is There Over Utilization of

Live Activity

AUA

10SFOPLS08

Critical Discussion: Is There Over Utilization of

Live Activity

AUA

10SFOPLS08

Critical Discussion: Is There Over Utilization of

Live Activity

AUA

10SFOPLS09

State-of-the-Art Lecture: The Evolving Role of Ima

Live Activity

AUA

10SFOPLS09

State-of-the-Art Lecture: The Evolving Role of Ima

Live Activity

AUA

10SFOPLS09

State-of-the-Art Lecture: The Evolving Role of Ima

Live Activity

AUA

10SFOPLS10

Panel Discussion: Radiation Exposure to the Patie

Live Activity

AUA

10SFOPLS10

Panel Discussion: Radiation Exposure to the Patie

Live Activity

AUA

10SFOPLS10

Panel Discussion: Radiation Exposure to the Patie

Live Activity

AUA

10SFOPLS11

Late Breaking News: Recommendations for Processin

Live Activity

AUA

10SFOPLS11

Late Breaking News: Recommendations for Processin

Live Activity

AUA

10SFOPLS11

Late Breaking News: Recommendations for Processin

Live Activity

AUA

10SFOPLT01

Highlights from Monday Sessions: Infection/Inflamm

Live Activity

AUA

10SFOPLT01

Highlights from Monday Sessions: Infection/Inflamm

Live Activity

AUA

10SFOPLT02

Reconstruction/Urinary Diversion

Live Activity

AUA

10SFOPLT02

Reconstruction/Urinary Diversion

Live Activity

AUA

10SFOPLT02

Reconstruction/Urinary Diversion

Live Activity

AUA

10SFOPLT03

The Societe Internationale d'Urologie (SIU) Lectur

Live Activity

AUA

10SFOPLT03

The Societe Internationale d'Urologie (SIU) Lectur

Live Activity

AUA

10SFOPLT03

The Societe Internationale d'Urologie (SIU) Lectur

Live Activity

AUA

10SFOPLT04

AUA Guideline Presentation: BPH - Kevin T. McVary

Live Activity

AUA

San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.50

6/3/10

0.50

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

10SFOPLT04

AUA Guideline Presentation: BPH - Kevin T. McVary

Live Activity

AUA

10SFOPLT04

AUA Guideline Presentation: BPH - Kevin T. McVary

Live Activity

AUA

10SFOPLT05

Point-Counterpoint: Preserving the Infected Prost

Live Activity

AUA

10SFOPLT05

Point-Counterpoint: Preserving the Infected Prost

Live Activity

AUA

10SFOPLT05

Point-Counterpoint: Preserving the Infected Prost

Live Activity

AUA

10SFOPLT06

State-of-the-Art Lecture: Is Prostate Cancer an I

Live Activity

AUA

10SFOPLT06

State-of-the-Art Lecture: Is Prostate Cancer an I

Live Activity

AUA

10SFOPLT06

State-of-the-Art Lecture: Is Prostate Cancer an I

Live Activity

AUA

10SFOPLT07

State-of-the-Art Lecture: Targeting the Seven Kid

Live Activity

AUA

10SFOPLT07

State-of-the-Art Lecture: Targeting the Seven Kid

Live Activity

AUA

10SFOPLT07

State-of-the-Art Lecture: Targeting the Seven Kid

Live Activity

AUA

10SFOPLT08

State-of-the-Art Lecture: Multiparametric 3T Endo

Live Activity

AUA

10SFOPLT08

State-of-the-Art Lecture: Multiparametric 3T Endo

Live Activity

AUA

10SFOPLT08

State-of-the-Art Lecture: Multiparametric 3T Endo

Live Activity

AUA

10SFOPLT09

Panel Discussion: Management of Early Stage Prosta

Live Activity

AUA

10SFOPLT09

Panel Discussion: Management of Early Stage Prosta

Live Activity

AUA

10SFOPLT09

Panel Discussion: Management of Early Stage Prosta

Live Activity

AUA

10SFOPLT10

Panel Discussion: Immunotherapy in Urologic Cance

Live Activity

AUA

10SFOPLT10

Panel Discussion: Immunotherapy in Urologic Cance

Live Activity

AUA

10SFOPLT10

Panel Discussion: Immunotherapy in Urologic Cance

Live Activity

AUA

10SFOPLT11

Late Breaking News: Randomized Phase III trial of

Live Activity

AUA

10SFOPLT11

Late Breaking News: Randomized Phase III trial of

Live Activity

AUA

10SFOPLT11

Late Breaking News: Randomized Phase III trial of

Live Activity

AUA

10SFOPLT12

Panel Discussion: Inflammation and Urologic Diseas

Live Activity

AUA

San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.50

10SFOPLT12

Panel Discussion: Inflammation and Urologic Diseas

Live Activity

AUA

10SFOPLT12

Panel Discussion: Inflammation and Urologic Diseas

Live Activity

AUA

10SFOPLT13

Late Breaking News - Prolonged Event Free Survival

Live Activity

AUA

10SFOPLT13

Late Breaking News - Prolonged Event Free Survival

Live Activity

AUA

10SFOPLT13

Late Breaking News - Prolonged Event Free Survival

Live Activity

AUA

10SFOPLT14

Panel Discussion: Does Pre-Operative Evaluation a

Live Activity

AUA

10SFOPLT14

Panel Discussion: Does Pre-Operative Evaluation a

Live Activity

AUA

10SFOPLT14

Panel Discussion: Does Pre-Operative Evaluation a

Live Activity

AUA

10SFOPLT14

Panel Discussion: Does Pre-Operative Evaluation a

Live Activity

AUA

10SFOPLTH01

Health Policy - William F. Gee, Localized Prostate

Live Activity

AUA

10SFOPLTH02

Pediatrics Urology - Hilary Copp, MD, Infection-Jo

Live Activity

AUA

10SFOPLTH03

Basic Science- Simon W. Hayward, PhD, Stone Diseas

Live Activity

AUA

10SFOPLTH04

Penile and Urethral Cancer -Anthony Puras-Baez, MD

Live Activity

AUA

10SFOPLTH05

Sexual Function/Dysfunction-Ronald W. Lewis, MD, R

Live Activity

AUA

10SFOPLTH05

Sexual Function/Dysfunction-Ronald W. Lewis, MD, R

Live Activity

AUA

10SFOPLTH06

Urodynamics, BPH/LUTS, Laparoscopic Technology- Ke

Live Activity

AUA

10SFOPLTH06

Urodynamics, BPH/LUTS, Laparoscopic Technology- Ke

Live Activity

AUA

10SFOPLTH07

Laparoscopic Oncology - Ravi Munver, MD, Endourolo

Live Activity

AUA

10SFOPLTH07

Laparoscopic Oncology - Ravi Munver, MD, Endourolo

Live Activity

AUA

10SFOPLTH08

Kidney Cancer - Christopher G. Wood, MD, Bladder C

Live Activity

AUA

10SFOPLTH08

Kidney Cancer - Christopher G. Wood, MD, Bladder C

Live Activity

AUA

10SFOPLTH09

Uro-Pathology- Christopher J. Kane, MD, Uro-pathol

Live Activity

AUA

10SFOPLTH09

Uro-Pathology- Christopher J. Kane, MD, Uro-pathol

Live Activity

AUA

10SFOPLW01

Highlights from Tuesday Sessions: Bladder/Kidney

Live Activity

AUA

San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA

6/3/10

0.50

6/3/10

0.50

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

10SFOPLW01

Highlights from Tuesday Sessions: Bladder/Kidney

Live Activity

AUA

10SFOPLW01

Highlights from Tuesday Sessions: Bladder/Kidney

Live Activity

AUA

10SFOPLW02

The European Association of Urology (EAU) Lecture:

Live Activity

AUA

10SFOPLW02

The European Association of Urology (EAU) Lecture:

Live Activity

AUA

10SFOPLW02

The European Association of Urology (EAU) Lecture:

Live Activity

AUA

10SFOPLW02

The European Association of Urology (EAU) Lecture:

Live Activity

AUA

10SFOPLW03

State-of-the-Art Lecture: A Critical Discussion o

Live Activity

AUA

10SFOPLW03

State-of-the-Art Lecture: A Critical Discussion o

Live Activity

AUA

10SFOPLW03

State-of-the-Art Lecture: A Critical Discussion o

Live Activity

AUA

10SFOPLW03

State-of-the-Art Lecture: A Critical Discussion o

Live Activity

AUA

10SFOPLW04

Point-Counterpoint: Treatment Paradigms for Ejac

Live Activity

AUA

10SFOPLW04

Point-Counterpoint: Treatment Paradigms for Ejac

Live Activity

AUA

10SFOPLW04

Point-Counterpoint: Treatment Paradigms for Ejac

Live Activity

AUA

10SFOPLW04

Point-Counterpoint: Treatment Paradigms for Ejac

Live Activity

AUA

10SFOPLW05

State-of-the-Art Lecture: Evidence-based Recovery

Live Activity

AUA

10SFOPLW05

State-of-the-Art Lecture: Evidence-based Recovery

Live Activity

AUA

10SFOPLW05

State-of-the-Art Lecture: Evidence-based Recovery

Live Activity

AUA

10SFOPLW06

Critical Discussion: Nocturia in Elderly Patients

Live Activity

AUA

10SFOPLW06

Critical Discussion: Nocturia in Elderly Patients

Live Activity

AUA

10SFOPLW06

Critical Discussion: Nocturia in Elderly Patients

Live Activity

AUA

10SFOPLW07

Panel Discussion: The Management of Recalcitrant

Live Activity

AUA

10SFOPLW07

Panel Discussion: The Management of Recalcitrant

Live Activity

AUA

10SFOPLW07

Panel Discussion: The Management of Recalcitrant

Live Activity

AUA

10SFOPLW08

State-of-the-Art Lecture: Robotic Surgery: Curre

Live Activity

AUA

San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA

6/3/10

0.50

6/3/10

0.50

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

10SFOPLW08

State-of-the-Art Lecture: Robotic Surgery: Curre

Live Activity

AUA

10SFOPLW08

State-of-the-Art Lecture: Robotic Surgery: Curre

Live Activity

AUA

10SFOPLW09

AHA/ACS/AUA Science Advisory: Androgen Deprivatio

Live Activity

AUA

10SFOPLW09

AHA/ACS/AUA Science Advisory: Androgen Deprivatio

Live Activity

AUA

10SFOPLW09

AHA/ACS/AUA Science Advisory: Androgen Deprivatio

Live Activity

AUA

10SFOPLW10

Late Breaking News: Reduction of Patients' Decisio

Live Activity

AUA

10SFOPLW10

Late Breaking News: Reduction of Patients' Decisio

Live Activity

AUA

10SFOPLW10

Late Breaking News: Reduction of Patients' Decisio

Live Activity

AUA

10SFOPLW11

State-of-the-Art Lecture: Surgical Simulation: L

Live Activity

AUA

10SFOPLW11

State-of-the-Art Lecture: Surgical Simulation: L

Live Activity

AUA

10SFOPLW11

State-of-the-Art Lecture: Surgical Simulation: L

Live Activity

AUA

10SFOPLW12

Presidential Address The Future of Urology – Anton

Live Activity

AUA

10SFOPLW12

Presidential Address The Future of Urology – Anton

Live Activity

AUA

10SFOPLW12

Presidential Address The Future of Urology – Anton

Live Activity

AUA

10SFOPLW13

Ramon Guiteras Lecture: Regenerative Medicine, Ti

Live Activity

AUA

10SFOPLW13

Ramon Guiteras Lecture: Regenerative Medicine, Ti

Live Activity

AUA

10SFOPLW13

Ramon Guiteras Lecture: Regenerative Medicine, Ti

Live Activity

AUA

San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA San Fancisco, CA

6/3/10

0.50

6/3/10

0.50

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.25

6/3/10

0.50

6/3/10

0.50

6/3/10

0.50

Sub Total for 2010 AMA PRA Category 1 Credits™:

64.50

Year: 2009 Program Code

Program

09CHIFR03

09CHIFR03 AACU/HP Forum

09CHIFR05

09CHIFR05 History Forum

09CHIMP02

09CHIMP02 Infect/Inflam.of Genitourin.Tract:IC

09CHIMP02

09CHIMP02 Infect/Inflam.of Genitourin.Tract:IC

09CHIMP02

09CHIMP02 Infect/Inflam.of Genitourin.Tract:IC

09CHIMP08

09CHIMP08 Prostate Cancer: Basic Research II

AMA PRA Category 1 Credits™

Learning Format

Accredited Provider

Location

Date

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live

AUA

Chicago, IL

4/30/09

3.00

AUA

Chicago, IL

4/30/09

4.50

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

09CHIMP09

09CHImp09 Prostate Cancer: Staging II

09CHIMP21

09CHIMP21 Kidney Cancer: Evaluation & Staging I

09CHIMP23

09CHIMP23 Kidney Cancer: Evaluation & Staging II

09CHIMP23

09CHIMP23 Kidney Cancer: Evaluation & Staging II

09CHIMP24

09CHIMP24 Pediatrics: Basic Research

09CHIMP24

09CHIMP24 Pediatrics: Basic Research

09CHIMP30

09CHIMP30 Urodyn./Incontin/Fem Urol:Neurogenic Voi

09CHIMP36

09CHIMP36 Peds Surg.:Reconstruct, Diversion,Endour

09CHIMP36

09CHIMP36 Peds Surg.:Reconstruct, Diversion,Endour

09CHIMP38

09CHIMP38 Bladder Cancer: Detection and Screening

09CHIMP48

09CHIMP48 Stone Disease: Eval & Medical Management

09CHIMP51

09CHIMP51 Urodynam/Incontin/Fem Urol:Fem Urol II

09CHIMP52

09CHIMP52 Urodyn/Incon/Fem Urol:NonNeurogenic...II

09CHIMP54

09CHIMP54 Stone Disease:SWL,Ureterscop., Percut II

09CHIMP56

09CHIMP56 Urody/Incon/Fem Uro:Incon Eval&Thera III

09CHIMP56

09CHIMP56 Urody/Incon/Fem Uro:Incon Eval&Thera III

09CHIMP59

09CHIMP59 Bladder Cancer: Superficial I

09CHIMP61

09CHIMP61 Stone Disease:Research/New Technol I

09CHIMP63

09CHIMP63 Urodyn/Incont/Fem Uro:Incont Eval&TherIV

09CHIMP65

09CHIMP65 BPH: Surg. Therapy & New Technol I

09CHIMP68

09CHIMP68 Stone Disease: Research/New Technol II

09CHIMP70

09CHIMP70 Transplantation & Vascular Surgery I

09CHIMP73

09CHIMP73 BPH: Surg. Therapy & New Technology II

09CHIMP77

09CHIMP77 Transplantation & Vascular Surgery II

09CHIPLM01

09CHIPLM01 Endourology

09CHIPLM01

09CHIPLM01 Endourology

09CHIPLM01

09CHIPLM01 Endourology

09CHIPLM02

09CHIPLM02 BPH/LUTS

09CHIPLM02

09CHIPLM02 BPH/LUTS

09CHIPLM02

09CHIPLM02 BPH/LUTS

09CHIPLM03

09CHIMPLM03 Pediatric Urology

09CHIPLM03

09CHIMPLM03 Pediatric Urology

09CHIPLM03

09CHIMPLM03 Pediatric Urology

09CHIPLM04

09CHIPLM04 Antimicrobial Prophylaxis in Urology

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

09CHIPLM04

09CHIPLM04 Antimicrobial Prophylaxis in Urology

09CHIPLM04

09CHIPLM04 Antimicrobial Prophylaxis in Urology

09CHIPLM05

09CHIPLM05 Urolog Assoc of Asia Lect. "Genitourin

09CHIPLM05

09CHIPLM05 Urolog Assoc of Asia Lect. "Genitourin

09CHIPLM05

09CHIPLM05 Urolog Assoc of Asia Lect. "Genitourin

09CHIPLM06

09CHIPLM06 The Overlap between Prostatitis & Other

09CHIPLM06

09CHIPLM06 The Overlap between Prostatitis & Other

09CHIPLM06

09CHIPLM06 The Overlap between Prostatitis & Other

09CHIPLM07

09CHIPLM07 A Re-Look at the Use of Amitriptyline

09CHIPLM07

09CHIPLM07 A Re-Look at the Use of Amitriptyline

09CHIPLM08

09CHIPLM08 Botulinum Toxin Type A BOTOX Demo

09CHIPLM08

09CHIPLM08 Botulinum Toxin Type A BOTOX Demo

09CHIPLM09

09CHIPLM09 Random. Clinic. Trials: Treat. of SUI

09CHIPLM09

09CHIPLM09 Random. Clinic. Trials: Treat. of SUI

09CHIPLM10

09CHIPLM10 Neurogenic Bladder, 2009

09CHIPLM10

09CHIPLM10 Neurogenic Bladder, 2009

09CHIPLM11

09CHIPLM11 Manag. the Urethra at the Time of Prola

09CHIPLM11

09CHIPLM11 Manag. the Urethra at the Time of Prola

09CHIPLM12

09CHIPLM12 The Impact of Toxicants on Male Reprodu

09CHIPLM12

09CHIPLM12 The Impact of Toxicants on Male Reprodu

09CHIPLM13

09CHIPLM13 Declin. Sex. Funct. in the Aging Male

09CHIPLM13

09CHIPLM13 Declin. Sex. Funct. in the Aging Male

09CHIPLM14

09CHIPLM14 Decision Making in the Severely Oligosp

09CHIPLM14

09CHIPLM14 Decision Making in the Severely Oligosp

09CHIPLM15

09CHIPLM15 AUA Best Pract. State.:Male Infertility

09CHIPLM15

09CHIPLM15 AUA Best Pract. State.:Male Infertility

09CHIPLM16

09CHIPLM16 Headline Results of the REDUCE Trial

09CHIPLM16

09CHIPLM16 Headline Results of the REDUCE Trial

09CHIPLS01

09CHIPLS01 AUA Health Policy

09CHIPLS01

09CHIPLS01 AUA Health Policy

09CHIPLS02

09CHIPLS02 ABU Update

09CHIPLS02

09CHIPLS02 ABU Update

09CHIPLS03

09CHIPLS03 Manpower in Urology Worldwide

09CHIPLS03

09CHIPLS03 Manpower in Urology Worldwide

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

09CHIPLS04

09CHIPLS04 Can We Prevent Hypospadius?

09CHIPLS04

09CHIPLS04 Can We Prevent Hypospadius?

09CHIPLS05

09CHIPLS05 Transit of Care: Teen Spina Bifida Pat

09CHIPLS05

09CHIPLS05 Transit of Care: Teen Spina Bifida Pat

09CHIPLS06

09CHIPLS06 Entercystoplasty:What is the Risk of Ma

09CHIPLS07

09CHIPLS07 The Wet Child. What is New?

09CHIPLS08

09CHIPLS08 Lap in the Treatment of Non-Palp Teste

09CHIPLS09

09CHIPLS09 AUA Clin. Guideline on Pediatric VUR

09CHIPLS09

09CHIPLS09 AUA Clin. Guideline on Pediatric VUR

09CHIPLS10

09CHIPLS10 Imaging is Everything:The Evolution

09CHIPLS10

09CHIPLS10 Imaging is Everything:The Evolution

09CHIPLS11

09CHIPLS11 The Evolving Role of Image Guided Thera

09CHIPLS11

09CHIPLS11 The Evolving Role of Image Guided Thera

09CHIPLS12

09CHIPLS12 Pursuit of the Benign Prostrate:From TU

09CHIPLS12

09CHIPLS12 Pursuit of the Benign Prostrate:From TU

09CHIPLS13

09CHIPLS13 News from the Europ. Random. Study

09CHIPLS13

09CHIPLS13 News from the Europ. Random. Study

09CHIPLS14

09CHIPLS14 Initial Mortal. Results from the Prosta

09CHIPLS14

09CHIPLS14 Initial Mortal. Results from the Prosta

09CHIPLS15

09CHIPLS15 Stromal-Epithelial Interactions in Pros

09CHIPLS15

09CHIPLS15 Stromal-Epithelial Interactions in Pros

09CHIPLT01

09CHIPLT01 Hightlights: Infection/Inflammation

09CHIPLT01

09CHIPLT01 Hightlights: Infection/Inflammation

09CHIPLT02

09CHIPLT02 Highlights: Sex. Function/Dysfunction

09CHIPLT02

09CHIPLT02 Highlights: Sex. Function/Dysfunction

09CHIPLT03

09CHIPLT03 Highlights: Urodynamics and Female Urol

09CHIPLT03

09CHIPLT03 Highlights: Urodynamics and Female Urol

09CHIPLT04

09CHIPLT04 Reconstructive/Urinary Diversion

09CHIPLT04

09CHIPLT04 Reconstructive/Urinary Diversion

09CHIPLT05

09CHIPLT05 Lymph Node Dissection in Urol. Cancers

09CHIPLT05

09CHIPLT05 Lymph Node Dissection in Urol. Cancers

09CHIPLT06

09CHIPLT06 Mgmt:Incident. Discov. Small Renal Mass

09CHIPLT06

09CHIPLT06 Mgmt:Incident. Discov. Small Renal Mass

09CHIPLT07

09CHIPLT07 Advanced Imaging for Prost. & Kid. Canc

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

09CHIPLT07

09CHIPLT07 Advanced Imaging for Prost. & Kid. Canc

09CHIPLT08

09CHIPLT08 Diet & Lifestyle Changes & Prostate Can

09CHIPLT08

09CHIPLT08 Diet & Lifestyle Changes & Prostate Can

09CHIPLT09

09CHIPLT09 The Timing of Radiation Therapy:Margin

09CHIPLT09

09CHIPLT09 The Timing of Radiation Therapy:Margin

09CHIPLT09

09CHIPLT09 The Timing of Radiation Therapy:Margin

09CHIPLT10

09CHIPLT10 Should Intermitt. Androgen Ablation Be

09CHIPLT10

09CHIPLT10 Should Intermitt. Androgen Ablation Be

09CHIPLT10

09CHIPLT10 Should Intermitt. Androgen Ablation Be

09CHIPLT11

09CHIPLT11 The Androgen Receptor in Prost. Cancer

09CHIPLT11

09CHIPLT11 The Androgen Receptor in Prost. Cancer

09CHIPLT11

09CHIPLT11 The Androgen Receptor in Prost. Cancer

09CHIPLT12

09CHIPLT12 Cancer Evolution

09CHIPLT12

09CHIPLT12 Cancer Evolution

09CHIPLT12

09CHIPLT12 Cancer Evolution

09CHIPLT13

09CHIPLT13 New Approach to Mgmt of Cancer Invasive

09CHIPLT13

09CHIPLT13 New Approach to Mgmt of Cancer Invasive

09CHIPLT13

09CHIPLT13 New Approach to Mgmt of Cancer Invasive

09CHIPLT14

09CHIPLT14 Prostate Specific Antigen (PSA)

09CHIPLT14

09CHIPLT14 Prostate Specific Antigen (PSA)

09CHIPLT14

09CHIPLT14 Prostate Specific Antigen (PSA)

09CHIPLT15

09CHIPLT15 A Review of AUA Guidelines:Mgmt Non-Mus

09CHIPLT15

09CHIPLT15 A Review of AUA Guidelines:Mgmt Non-Mus

09CHIPLT15

09CHIPLT15 A Review of AUA Guidelines:Mgmt Non-Mus

09CHIPLTH01

09CHIPLTH01 Loc. Prost. Can,Advanc. Prost Can. Ped

09CHIPLTH01

09CHIPLTH01 Loc. Prost. Can,Advanc. Prost Can. Ped

09CHIPLTH02

09CHIPLTH02 Infection, Infertility, Basic Science

09CHIPLTH02

09CHIPLTH02 Infection, Infertility, Basic Science

09CHIPLTH03

09CHIPLTH03 Stone Dis,Transpl. Vas. Surg,Penile&Ur

09CHIPLTH03

09CHIPLTH03 Stone Dis,Transpl. Vas. Surg,Penile&Ur

09CHIPLTH04

09CHIPLTH04 Testis Can, Trauma/Reconstr Surg,Sex F

09CHIPLTH04

09CHIPLTH04 Testis Can, Trauma/Reconstr Surg,Sex F

09CHIPLTH05

09CHIPLTH05 Robot. Surg, Fem Urol/Incont, Urodynam

09CHIPLTH05

09CHIPLTH05 Robot. Surg, Fem Urol/Incont, Urodynam

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

09CHIPLTH06

09CHIPLTH06 BPH/LUTS, Lap Technol, Lap Oncology

09CHIPLTH06

09CHIPLTH06 BPH/LUTS, Lap Technol, Lap Oncology

09CHIPLTH07

09CHIPLTH07 Endourol., Outcomes Analysis, Kid. Can

09CHIPLTH07

09CHIPLTH07 Endourol., Outcomes Analysis, Kid. Can

09CHIPLTH08

09CHIPLTH08 Blad. Can., Urin. Diversion, Uroradiol

09CHIPLTH08

09CHIPLTH08 Blad. Can., Urin. Diversion, Uroradiol

09CHIPLTH09

09CHIPLTH09 Uropath, Office Mgmt Pract, Health Pol

09CHIPLTH09

09CHIPLTH09 Uropath, Office Mgmt Pract, Health Pol

09CHIPLW01

09CHIPLW01 Bladder/Kidney Cancer

09CHIPLW01

09CHIPLW01 Bladder/Kidney Cancer

09CHIPLW01

09CHIPLW01 Bladder/Kidney Cancer

09CHIPLW02

09CHIPLW02 Prostate Cancer

09CHIPLW02

09CHIPLW02 Prostate Cancer

09CHIPLW02

09CHIPLW02 Prostate Cancer

09CHIPLW03

09CHIPLW03 Basic Research

09CHIPLW03

09CHIPLW03 Basic Research

09CHIPLW03

09CHIPLW03 Basic Research

09CHIPLW04

09CHIPLW04 Multicenter Clin. Valid. of PITX2 Methy

09CHIPLW04

09CHIPLW04 Multicenter Clin. Valid. of PITX2 Methy

09CHIPLW04

09CHIPLW04 Multicenter Clin. Valid. of PITX2 Methy

09CHIPLW05

09CHIPLW05 Should We Treat Hypogonadism in Men

09CHIPLW05

09CHIPLW05 Should We Treat Hypogonadism in Men

09CHIPLW05

09CHIPLW05 Should We Treat Hypogonadism in Men

09CHIPLW06

09CHIPLW06 The Eval. & Treatment of Priapism

09CHIPLW06

09CHIPLW06 The Eval. & Treatment of Priapism

09CHIPLW07

09CHIPLW07 The European Association of Urology

09CHIPLW07

09CHIPLW07 The European Association of Urology

09CHIPLW08

09CHIPLW08 The Surg. Mgmt. of Peyronie's Disease

09CHIPLW08

09CHIPLW08 The Surg. Mgmt. of Peyronie's Disease

09CHIPLW09

09CHIPLW09 The Mgmt. of Urin. Retent.:Frail Elder

09CHIPLW09

09CHIPLW09 The Mgmt. of Urin. Retent.:Frail Elder

09CHIPLW10

09CHIPLW10 The Use of Buccal Mucosa for Urethropla

09CHIPLW10

09CHIPLW10 The Use of Buccal Mucosa for Urethropla

09CHIPLW11

09CHIPLW11 Genitourin. Can. in Pat. After Renal Tr

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.50

AUA

Chicago, IL

4/30/09

0.25

09CHIPLW11

09CHIPLW11 Genitourin. Can. in Pat. After Renal Tr

09CHIPLW12

09CHIPLW12 The Core Curriculum for Urology

09CHIPLW12

09CHIPLW12 The Core Curriculum for Urology

09CHIPLW13

09CHIPLW13 The AUA's Plan:Advanc.Urol Research&Car

09CHIPLW13

09CHIPLW13 The AUA's Plan:Advanc.Urol Research&Car

09CHIPLW14

09CHIPLW14 Presidential Address - John M. Barry,MD

09CHIPLW14

09CHIPLW14 Presidential Address - John M. Barry,MD

09CHIPLW15

09CHIPLW15 Health Care for the 21st Century

09CHIPLW15

09CHIPLW15 Health Care for the 21st Century

09CHIPOD01

09CHIPOD01 Adrenal:Benign Disease,Tumors,Physiolog

09CHIPOD01

09CHIPOD01 Adrenal:Benign Disease,Tumors,Physiolog

09CHIPOD01

09CHIPOD01 Adrenal:Benign Disease,Tumors,Physiolog

09CHIPOD02

09CHIPOD02 Trauma and Reconstructive Surgery I

09CHIPOD05

09CHIpod05 Prostate Cancer: Staging I

09CHIPOD07

09CHIpod07 Infect/Inflam-Genito.Tract:Prost&Gen I

09CHIPOD07

09CHIpod07 Infect/Inflam-Genito.Tract:Prost&Gen I

09CHIPOD10

09CHIpod10 Infect/Inflam of Genit.ract:Pro.&Gen II

09CHIPOD13

09CHIPOD13 Peds: Congential Anomalies-LUT&Gen II

09CHIPOD13

09CHIPOD13 Peds: Congential Anomalies-LUT&Gen II

09CHIPOD14

09CHIPOD14 Prostate Cancer: Localized I

09CHIPOD14

09CHIPOD14 Prostate Cancer: Localized I

09CHIPOD15

09CHIPOD15 Peds:Congenital Anomalies-Kidney&Ureter

09CHIPOD15

09CHIPOD15 Peds:Congenital Anomalies-Kidney&Ureter

09CHIPOD17A

09CHIPOD17A Infect/Inflam of Gen.Tract:Kid&Blad II

09CHIPOD17A

09CHIPOD17A Infect/Inflam of Gen.Tract:Kid&Blad II

09CHIPOD21

09CHIPOD21 Sex. Funct/Dysfunct/Andrology:Peyronie'

09CHIPOD22

09CHIPOD22 Peds: Myelodysplasia, Neuropath.Blad.

09CHIPOD22

09CHIPOD22 Peds: Myelodysplasia, Neuropath.Blad.

09CHIPOD25

09CHIPOD25 Penis/Testis/Urethra:Benign&Mal. Dis.II

09CHIPOD25

09CHIPOD25 Penis/Testis/Urethra:Benign&Mal. Dis.II

09CHIPOD26

09CHIPOD26 Sex. Funct/Dysfunct/Androl.:Eval I

09CHIPOD28

09CHIPOD28 Peds: Trauma, Tumors, Stone ... I

09CHIPOD28

09CHIPOD28 Peds: Trauma, Tumors, Stone ... I

09CHIPOD29

09CHIPOD29 Peds:Trauma, Tumors, Stone Disease ..II

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

0.25

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

09CHIPOD29

09CHIPOD29 Peds:Trauma, Tumors, Stone Disease ..II

09CHIPOD30

09CHIPOD30 Sex Funct/Dysfunct/Androl:Surgical Ther

09CHIPOD30

09CHIPOD30 Sex Funct/Dysfunct/Androl:Surgical Ther

09CHIPOD32

09CHIPOD32 Prostate Cancer: Localized III

09CHIPOD33

09CHIPOD33 Urodyn/Incont/Fem Urol:Pelvic Prolapse

09CHIPOD33

09CHIPOD33 Urodyn/Incont/Fem Urol:Pelvic Prolapse

09CHIPOD34

09CHIPOD34 Sex Funct/Dyfunct/Androl:Med& ... I

09CHIPOD35

09CHIPOD35 Stone Disease:SWL, Ureteroscopic, I

09CHIPOD38

09CHIPOD38 Urodyn/Incont/Fem Urol:Fem Urol I

09CHIPOD39

09CHIPOD39 Urodyn/Incont/Fem Urol:Incont Eval...II

09CHIPOD43

09CHIPOD43 BPH: Medical & Hormonal Therapy I

09CHIPOD46

09CHIPOD46 Infertility: Evaluation

09CHIPOD48

09CHIPOD48 Imaging & Radiology II

Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity Live Activity

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

AUA

Chicago, IL

4/30/09

2.00

Sub Total for 2009 AMA PRA Category 1 Credits™:

189.00

Year: 2008 Program Code

Program

08ORLAMWC05

08 Advances in Imaging for Urologic Oncology

08ORLAMWC103

08 Surgical Treatment of Stress Incontinence

08ORLAMWC104

08 Surgical Treatment of Urge Incontinence

08ORLAMWC105

08 SWL: A Problem of Technology or Technique?

08ORLAMWC114

08 The Great Plague:Pandemics Can Change History

08ORLAMWC119

08 Management of Urethral Strictures in Ancient

08ORLAMWC12

08 Approached to High-Risk & Locally Advanced CaP

08ORLAMWC121

08 The Story of the Boari Flap

08ORLAMWC132

08Urology & the Aztecs: A View into Pre-Columbian

08ORLAMWC136

08 Where are we in Mid-2008?

08ORLAMWC24

08 Case Studies

08ORLAMWC25

08 Clin. Utility of PSA Velocity and Doubling Time

08ORLAMWC28

08 Contempor. Approaches to Low Risk Localized CaP

08ORLAMWC32

08 Diagnostic Options

08ORLAMWC37

08 Epidemiology

08ORLAMWC38

08 Erectile Dysfunction: Etiology& Pathophysiology

08ORLAMWC39

08 Europ. Assoc. of Urology (EAU) Lecture Loca

08ORLAMWC43

08 Fire from Urine: Henning Brand's Search

Learning Format

Accredited Provider

Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

Location Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD

Date

AMA PRA Category 1 Credits™

8/1/08

0.25

8/1/08

0.25

8/1/08

0.50

8/1/08

0.25

8/1/08

0.25

8/1/08

0.25

8/1/08

0.25

8/1/08

0.25

8/1/08

0.25

8/1/08

0.50

8/1/08

0.25

8/1/08

0.50

8/1/08

0.25

8/1/08

0.25

8/1/08

0.25

8/1/08

0.50

8/1/08

0.25

8/1/08

0.25

08ORLAMWC47

08 History of Randall's Plaques

08ORLAMWC55

08 John Duckett Mem. Lecture The Top-down Approac

08ORLAMWC60

08 Lichen Sclerosis: A New Epidemic?

08ORLAMWC61

08Local & Locally Advanced Prostate Cancer - 2008:

08ORLAMWC69

08 New Circumcision: The Controversy Revisited

08ORLAMWC70

08 Non-Surgical Treatment of Stress Incontinence

08ORLAMWC71

08 Non-Surgical Treatment of Urge Incontinence

08ORLAMWC75

08 Pediatric Urology

08ORLAMWC78

08 Penile Rehabilitation in the Radical Prostatect

08ORLAMWC82

08Pre-natal Detect. Hydronephrosis:Post-natal Diag

08ORLAMWC84

08 Prospects of Prostate Cancer Prevention

08ORLAMWC87

08 Prostatic Cryosurgery

08ORLAMWC88

08 PSA

Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material Enduring Material

AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA AUA

Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD Linthicum, MD

8/1/08

0.25

8/1/08

0.25

8/1/08

0.25

8/1/08

0.50

8/1/08

0.50

8/1/08

0.25

8/1/08

0.25

8/1/08

0.25

8/1/08

0.50

8/1/08

0.50

8/1/08

0.25

8/1/08

0.25

8/1/08

0.25

Sub Total for 2008 AMA PRA Category 1 Credits™:

Grand Total AMA PRA Category 1 Credits™:

9.75

725.75

Credit The American Urological Association verifies that the "AMA PRA Category 1 Credits™" were awarded as indicated. Effective January 4th, 2010, only AUA designated activities will be verified. Accreditation The American Urological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide medical education for physicians. The American Urological Association takes responsibility for the content, quality and scientific integrity of this CME activity.

SELF-CLAIMED CREDITS The activities noted below are self-claimed by the physician. These credits are being reported independently by the physician and not acknowledged as being a designated AUA activity. The physician takes full responsibility for any activity noted, and is responsible for the maintenance of documentation that will verify attendance at these activities. No self-claimed activities